In view of the high prevalence of malignancy in patients with anti‐TIF1‐γ‐positive DM and the poor prognosis in patients with malignancy, the early diagnosis of anti‐TIF1‐γ‐positive DM is very important. The gene discussed is TRIM33; the disease is dermatomyositis.